Public reporting states have low angioplasty rates

By Piriya Mahendra, medwireNews Reporter

US states in which public reporting of percutaneous coronary intervention (PCI) rates by catheterization laboratories is required may have a reduced rate of the procedure in acute myocardial infarction (AMI) patients, research suggests.

However, investigators led by Karen Joynt (Harvard School of Public Health, Boston, Massachusetts, USA) found no significant difference in AMI mortality between states that participate in public reporting and those that do not.

The authors say that there may be two reasons why public reporting leads to underuse of PCI. First, they suggest that the majority of the foregone PCI procedures may have been futile or unnecessary, and that public reporting leads clinicians to ensure that only the most appropriate procedures are performed.

Alternatively, they say, public reporting may encourage clinicians to avoid PCI in eligible patients due to concern over the risk for poor outcomes. "Our data cannot definitely differentiate between these two mechanisms," Joynt and team explain.

Specifically, they found that in 2010, AMI patients were significantly less likely to receive PCI in the public reporting states of New York, Massachusetts, and Pennsylvania, than in the nonpublic reporting states of Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware, at 37.7% versus 42.7%.

The difference in PCI rate was greatest among the 6708 patients with ST-segment-elevation MI and the 2194 patients with cardiogenic shock or cardiac arrest than the other patients, at 61.9% versus 68.0% and 41.5% versus 46.7%, respectively.

Joynt et al found that before Massachusetts began public reporting in 2005, the risk for PCI in AMI patients was comparable with the risk for PCI in nonreporting states, at 40.6% versus 41.8%. However, in 2010, the risk for undergoing PCI was significantly lower in Massachusetts than in nonreporting states, at 41.1% versus 45.6%.

Again, the difference in PCI rate was most pronounced among patients who had experienced cardiogenic shock or cardiac arrest, at 44.2% versus 36.6% before reporting began, and 43.9% versus 44.8% afterward.

In a related commentary, editorialist Mauro Moscucci (University of Miami, Florida, USA) writes: "The study by Joynt et al confirms the possible unintended consequences of public reporting, while highlighting its association with (or lack of association with) clinical outcomes."

He concludes: "These findings may help spearhead a new focus on procedures that, while perceived appropriate based on current use criteria, might not result in added benefit in selected patients."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine